Medicines that lower blood sugar, hide a low, or hide DKA

Some medicines lower blood sugar. Others barely move it, but take away the signals you rely on to know something is wrong. This page covers both, including the one medicine class that can lead to diabetic ketoacidosis (DKA) while your glucose reads normal.

Anything that causes lows is more of a concern when it is combined with insulin than it would be for someone who doesn't take insulin.

Medicines that push it down

Alcohol, including in medicine. Your liver stops releasing glucose while it clears alcohol. Some liquid medicines and syrups contain alcohol — read the label.

Some antibiotics. The fluoroquinolones — levofloxacin, moxifloxacin and ciprofloxacin — can move glucose in either direction, sometimes sharply. These are the practical ones to know: they are prescribed often, and the warning about blood sugar swings rarely gets mentioned at the pharmacy counter.

High-dose salicylates and quinine. Both are recognised causes of lows. They are uncommon, but they turn up in older prescriptions and in travel kits.

Beta blockers take away the alarm, not the fire

Beta blockers such as metoprolol, propranolol and bisoprolol barely move the number. What they take away is your ability to feel it move.

Your early warning for a low is mostly adrenaline: the shaking, the pounding heart, the sudden anxiety. That is your body telling you to eat something now. Beta blockers blunt exactly those signals. The low still happens; the alarm is turned down.

Sweating usually still gets through, because it runs on a different nerve pathway. For some people on a beta blocker, sweating and confusion are the only warnings left. It is the one signal people can still trust, and almost nobody is told that it survives.

Beta blockers are often the right drug after a heart attack or for blood pressure. This is about managing around them, not avoiding them.

SGLT2 inhibitors: when DKA arrives with a normal reading

SGLT2 inhibitors include empagliflozin (Jardiance), dapagliflozin (Forxiga) and canagliflozin (Invokana). They are type 2 diabetes drugs, but they are also prescribed for heart failure and kidney disease — so people with type 1 do end up on them.

They work by flushing glucose out through the urine. In type 1, that creates a specific trap: you can go into full diabetic ketoacidosis while your glucose meter reads normal. This is called euglycemic DKA.

The alarm you have relied on since diagnosis — a high number — may never sound. Health Canada and other regulators have flagged this risk specifically.

Using an SGLT2 inhibitor in type 1 diabetes is off-label in most places. It is a decision to make with a specialist, before starting — never a pill to try because it helped someone else. If you are already taking one and didn't know about this, it may be the most useful thing on this page — and a good reason to raise it with your prescriber and your diabetes team.